Related by context. All words. (Click for frequent words.) 65 BioSante Pharmaceuticals Announces 65 BioLineRx Ltd. TASE 63 Files Investigational 62 BLRX 62 DP VPA 60 Initiates Clinical 60 Submits Response 60 Initiates Enrollment 59 Files IND 59 Initiates Phase II 59 Receives Orphan Drug Designation 59 commercialize taliglucerase alfa 59 Submits IND 59 Reports Preclinical Data 58 Hadasit Bio Holdings 58 Completes Patient Enrollment 58 GTC recombinant form 58 Announces Tentative Approval 58 Initiates Phase III 58 Receives Complete Response 58 Receives Milestone Payment 58 Oral Calcitonin 58 Receives Orphan Drug 58 Presents Preclinical Data 58 Initiates Clinical Trial 58 GTC NASDAQ GTCB 58 Granted Orphan Drug 58 Receives Clearance 58 Hapto Biotech 58 Begin Clinical Trials 58 Enters Into Collaboration 58 BioLineRx 57 Submits Investigational 57 FDA Accepts 57 intravenous AAT 57 Fast Track Status 57 Paris IPN Euronext 57 Begins Dosing 57 Gamida Cell Ltd. 57 Can Fite BioPharma 57 developing Zerenex ferric 57 RedHill Biopharma 57 Inc. OTCBB BCLI 57 FOLOTYN ® 57 Loramyc ™ 56 Orphan Status 56 Submits NDA 56 Receives Approvable Letter 56 Protalix Biotherapeutics 56 novel emulsion formulation 56 Completes Dosing 56 NasVax 56 Receive Milestone Payment 56 Thalidomide Pharmion 56 Biologic License Application BLA 56 NASDAQ CGEN announced 56 Synerx 56 RedHill Biopharma Ltd. 56 Marketing Authorisation 56 Nabi HB R 56 Gamida 56 Orphan Designation 56 Marketing Authorisation Application MAA 56 Soliris TM eculizumab 56 histamine dihydrochloride 56 Submits Biologics License Application 56 Submits Supplemental 56 ARRY # 56 CancerVax Corporation 56 Australian Therapeutic Goods 56 Fovea Pharmaceuticals 56 Quark Pharmaceuticals 55 CureTech 55 NurOwn 55 highly purified pasteurized 55 CIP TRAMADOL ER 55 Kuvan R 55 SYCREST 55 Announce Licensing Agreement 55 Nasdaq CGEN 55 NYSE Amex PLX 55 Initiates Phase 2b 55 Junovan TM 55 Therapeutic Competitors Companies 55 Mivtach Shamir Holdings 55 Increlex TM 55 NerPharMa 55 Difimicin 55 Yeda Research 55 Adenuric R 55 Nasdaq EPCT 55 Civacir 55 Velac 55 Bioral Amphotericin B 55 Receives Tentative Approval 55 exclusive sublicense 55 D Pharm 55 Posiphen TM 55 Biological License Application 55 MOVIPREP R 55 Personalized Immunotherapy 55 sapropterin dihydrochloride 55 Alligator Bioscience AB 55 Orphan Drug status 55 vinorelbine emulsion 55 VIVITROL ® 55 Successfully Completes Phase 55 #D#C# 55 Presents Positive 55 Ercole Biotech 55 Cloretazine 55 Fresenius Biotech 55 Submits Application 55 Supplemental Biologics License Application 55 Orient Europharma 55 Pegloticase 54 sanofi aventis EURONEXT SAN 54 Initiate Clinical Trial 54 Corporation NASDAQ AMPL 54 Kiadis 54 Licenses Novel 54 InterfeRx 54 DiaPep# 54 JHP Pharmaceuticals LLC 54 BioLineRx Ltd. 54 Kosan dependence 54 Handok Pharmaceuticals 54 molecular imaging radiopharmaceutical 54 Receives CE Marking 54 Pennsaid Plus 54 NASDAQ NRGN 54 Idenix Novartis 54 Inc. www.micromet inc.com 54 KAHR Medical 54 successfully commercialize Iluvien 54 Orphan Drug designations 54 Presents Preclinical 54 HepaGam B 54 Potelligent Technology 54 HepeX B 54 Therapeutic Competitors Report 54 Rosetta Genomics Ltd. 54 lucinactant 54 Biologic License Application 54 candidate deforolimus 54 Giza Venture 54 Collategene 54 Genotyping Test 54 IND Application 54 Juvantia 54 Shonin approval 54 Preotact R 54 Announce License Agreement 54 markets HP Acthar 54 Optimata 54 PDE4 inhibitor 54 Somatuline R Autogel R 54 Receives Fast Track 54 Application MAA 54 NYSE AMEX IBIO 54 Alvesco ® 54 CAMPATH R 54 Sign License Agreement 54 beta 1a 54 Meets Primary Endpoint 54 Gentamicin Surgical Implant 54 Aposense 54 PHX# 54 Kuvan TM sapropterin 54 Cx# [002] 54 Systemic Delivery 54 Medinol Ltd. 54 Cenomed 54 OMAPRO ™ 54 outlicensed 54 mitogen activated ERK kinase 53 Ltd. TASE MISH 53 Files Provisional 53 GammaCan 53 PharmaStem 53 STEDESA 53 rasagiline tablets 53 R lenalidomide 53 Gets FDA Clearance 53 KRYSTEXXA TM pegloticase 53 Application BLA 53 inhaled AAT 53 Sankyo Pharma 53 Therapeutic Vaccine 53 Investigational Oral 53 Protalix Biotherapeutics Inc. 53 Crucell PER.C6 53 Neurim Pharmaceuticals 53 Extended Release Capsules 53 lipoglycopeptide 53 Panzem R 53 DPX Survivac 53 Torisel temsirolimus 53 Aviptadil 53 Genpharm 53 Receives Tentative FDA 53 Patent Covering 53 AMEX RGN 53 Martin Nicklasson CEO 53 Intravenous Human 53 submitted Biologics License 53 HuMax TAC 53 Positive Opinion 53 Yissum Research 53 Phenomix Corporation 53 Onconase 53 sublingual tablets 53 SYN X 53 MorphoSys proprietary 53 Onalta ™ 53 Mimpara R 53 Onalta TM 53 Receives NASDAQ 53 OTCBB GNTA 53 GA GCB 53 No Objection Letter 53 Norgine BV 53 Achieves Primary Endpoint 53 Taro Pharmaceutical 53 Nasdaq SGEN 53 Neulasta R 53 hyaluronidase enzyme 53 Ophthotech 53 miRNA therapeutics 53 Announces Poster Presentations 53 Compugen Ltd. 53 Anidulafungin 53 elbion GmbH 53 TSX SHQ 53 Restructures Operations 53 AMEX IVX 53 nasal calcitonin product 53 Vernalis plc 53 NV Organon 53 Receives Positive Opinion 53 miconazole MBT 53 Initiate Phase 53 methylnaltrexone bromide 53 Clinical Trial Application 53 Tikcro Technologies 53 Nasdaq BOSC 53 Ondansetron Injection 53 Recombinant Human 53 Veregen R 53 InSightec Ltd. 53 Kwang Dong 53 Sigma Tau Pharmaceuticals 52 FOR FURTHER INFORMATION ABOUT 52 highly selective adenosine 52 Industries Ltd. TASE 52 faropenem medoxomil 52 initiated Phase Ib 52 Peginterferon alfa 2b 52 Pivotal Phase III 52 Trobalt 52 Fast Track Designation 52 liver resection surgeries 52 Evoltra 52 polysaccharide polymer 52 Securite Sanitaire des Produits 52 Sanochemia Pharmazeutika AG 52 fluvoxamine maleate 52 vapreotide acetate 52 IND Investigational New 52 SciGen 52 BiolineRX 52 novel histone deacetylase 52 Reacquires 52 Secures Patent 52 SpeBio joint venture 52 Hextend R 52 k Premarket Notification 52 Regains NASDAQ 52 Rechovot 52 Announce Collaboration Agreement 52 Orphan Drug Status 52 humanized monoclonal 52 Maxy G# 52 YONDELIS R 52 Liprotamase 52 UPLYSO 52 EP #R 52 Vitrasert R 52 Cellcom Israel Ltd. 52 Amnon Cohen 52 Aloxi ® 52 RELISTOR subcutaneous injection 52 Creabilis Therapeutics 52 Vascular Wrap TM 52 Neopharm 52 Surfaxin lucinactant 52 rxRNA 52 Quark Biotech 52 Granulocyte Colony Stimulating Factor 52 Tibotec BVBA 52 Clalit HMO 52 Negev Beer Sheva 52 Phase #b/#a clinical 52 LymphoStat B TM 52 Exclusive License 52 ATG Fresenius S 52 Allovectin 7 r 52 NasdaqGM NTEC today 52 Hsp# Inhibitor 52 enoxaparin sodium injection 52 Pazopanib 52 OMP designation 52 Phase 2b Clinical Trial 52 non nucleoside inhibitor 52 AMEX IVX LSE IVX.L 52 generic enoxaparin 52 PF # [002] 52 novel therapeutic antibodies 52 Inovio AS 52 reslizumab 52 Begins Shipment 52 ABILIFY ® 52 Pharma GmbH 52 Tyzeka Sebivo 52 miconazole Lauriad R 52 Marketing Authorisation Application 52 Issued Patent 52 Protalix BioTherapeutics 52 LUCASSIN 52 Merz Pharmaceuticals GmbH 52 Obtains Exclusive 52 Announce Commencement 52 acetonide FA 52 Rotarix R 52 submit Biologics License 52 Idera Pharmaceuticals 52 Resubmission 52 Nipent R 52 Dalbavancin 52 elbion 52 BioDelivery Sciences Announces 52 Gadot Biochemical Industries 52 Morphine Sulfate 52 Hexvix ® 52 Azacitidine 52 Announce Licensing 52 NasdaqGM SPPI 52 immunotherapeutic vaccine 52 Retacrit 52 Defiante 52 Ceragenix 52 Orphan Drug designation 52 Luteinizing Hormone Releasing Hormone 52 ACOMPLIA R 52 JAK2 Inhibitor 52 Abstral ® 52 refractory chronic lymphocytic 52 Orphan designation 52 Obtains License 52 Announces Licensing Agreement 52 #/#mg 52 Kineret ® 52 Sigma Tau SpA 52 Gamida Cell 52 Cintredekin besudotox 52 Methylnaltrexone 52 CIP ISOTRETINOIN 52 Phase IIb clinical trials 52 IDE Investigational Device Exemption 51 Onalta 51 AMEX AKN today 51 Angiox ® 51 VISICOL R 51 gets USFDA nod 51 arsenic trioxide injection 51 Roche OTC RHHBY 51 supplemental Biologics License Application 51 aerosolized AAT 51 developing TB4 51 mesylate tablets approved 51 BRILINTA 51 Minapharm 51 Prolongs Survival 51 Initiates Phase 51 Prosaptide 51 NASDAQ FLML 51 Develop Novel 51 CEFF financings subject 51 Amends Agreement 51 Immunotherapeutic 51 Misonix Announces 51 volociximab 51 Comercial Mexicana Mexico 51 BioView 51 Taglich Brothers Initiates Coverage 51 CONBRIZA 51 SagaX 51 Announce Merger Agreement 51 Receives Favorable 51 Earns Milestone Payment 51 biosimilar filgrastim 51 Entocort 51 PDL# 51 Expedited Review 51 candidates Azedra TM 51 TSX PLB 51 supplemental biologics 51 XIAFLEX ® 51 Presents Positive Preclinical 51 Clinical Trials Agreement 51 GlaxoSmithKline plc GSK 51 Astellas Deutschland GmbH 51 Pafuramidine 51 HepaGam B R 51 Shigamabs 51 Tibotec Therapeutics division 51 Extends Collaboration 51 PentaStaph 51 hoFH 51 CIMZIA r 51 Archemix Corp. 51 XIAPEX 51 DeveloGen 51 Antibody Discovery 51 commercialize telaprevir 51 Probiodrug AG 51 Esbriet pirfenidone 51 SinuNase ™ 51 PGL# 51 Galenea 51 Grants Orphan Drug 51 ATryn ® 51 Risperidone Oral Solution 51 ELRN 51 synthetic peptide containing 51 Evoltra TM 51 Tostrex 51 Phase 2a Trial 51 SNT MC# 51 Sign Licensing Agreement 51 Nabi HB Intravenous 51 Oracea ® 51 OTCQX RHHBY 51 Rapinyl 51 Fovea Pharmaceuticals SA 51 Galderma SA 51 molecular chaperone regulation 51 Uvidem 51 Cellegesic TM nitroglycerin ointment 51 Binational Science 51 Pontifax 51 OTC IPXL 51 Selective Electrochemical Tumor Ablation 51 Quark Biotech Inc. 51 Files Patent Application 51 proprietary radiolabeled monoclonal 51 Atypical Antipsychotic 51 Drug Submission 51 5 HT3 antagonist 51 Argatroban 51 Ulrich Dauer CEO 51 RNA antagonists 51 GTC recombinant human 51 Regains Full 51 Myolimus 51 Tykerb lapatinib 51 eligen 51 MKC# MT 51 Loramyc 51 Dynepo TM 51 ORBIT II 51 Sanvar R 51 SoluBest 51 Falk Pharma 51 Loramyc TM 51 Severe Sepsis 51 TRX1 51 drug ISA# 51 Announces License Agreement 51 recombinant biopharmaceutical 51 balsalazide tablet 51 NUEDEXTA ™ 51 GeneraMedix Inc. 51 Prometheus Laboratories 51 Teva Pharmaceutical Industries TEVA.TA 51 Vaccinex 51 FDA Approvable Letter 51 BioNumerik 51 commercialize AzaSite 51 Sanquin 51 acyclovir Lauriad R 51 Ampligen r 51 Modrenal R 51 FDA Clears 51 Inc. Nasdaq SEPR 51 Solazed 51 RIGScan CR 51 IG HCR ;) CO 51 Marketing Authorization 51 OTCBB NVDL 51 Orphan Therapeutics 51 Serostim ® 51 buccal spray 51 R bendamustine hydrochloride 51 Loramyc R 51 Soliris eculizumab 51 Lantibio 51 Oracea TM 51 Initiates Dosing 51 Recommends Approval 51 ELTA Systems 51 Phase IIb Clinical Trial 51 udenafil 51 eprodisate KIACTA TM 51 taliglucerase alfa 51 treatmentof 51 Mylan Receives Approval 51 Taiho Pharmaceutical 51 Microbix Biosystems 51 TRISENOX ® 51 fibrotic disorders 51 NASDAQ ACOR 50 Files Shelf Registration Statement 50 ZFP Therapeutics 50 Theramex 50 Receives FDA Approvable 50 Directorate TPD 50 Completes Enrollment 50 License Option Agreement 50 Homspera TM 50 Yachin 50 XTL Biopharmaceuticals 50 Binational Industrial Research 50 Tamsulosin 50 TLR9 agonist 50 Deferiprone 50 Announces Initiation 50 TKM Ebola 50 Mycophenolate Mofetil 50 Merrimack Pharmaceuticals 50 Debiopharm SA 50 Salim Jubran 50 Davanat 50 Ltd. NASDAQ PTNR 50 InvaGen 50 Receives Marketing Authorization 50 Patent Upheld 50 lymphoid malignancies 50 Cellegesic 50 TransPharma Medical Ltd. 50 Teva TEVA.TA 50 IPSEN 50 adrenergic regulation 50 Emezine 50 receptor tyrosine kinase inhibitor 50 valopicitabine NM# 50 Vegenics 50 Romidepsin 50 Arzerra ofatumumab 50 Shows Statistically Significant 50 HDAC Inhibitor 50 sanofi aventis SNY 50 Tamiflu oseltamivir phosphate 50 Esbriet ® 50 Captisol enabled 50 Ecallantide 50 biotherapeutic drugs 50 KaloBios Pharmaceuticals 50 Friedreich Ataxia FRDA 50 Inc. Nasdaq MEDX 50 Synt em 50 Inc. OTCBB OXIS 50 Jaiva Technologies 50 Hadasit 50 Ceplene histamine dihydrochloride 50 Runcom Technologies Ltd. 50 ospemifene 50 Synerx Pharma 50 IL# PE#QQR 50 SinuNase TM 50 GW# [003] 50 Proquin XR 50 Novosom 50 ZEFTERA TM Zevtera TM 50 PNP inhibitor 50 Collaborators Publish 50 Poalim Capital Markets 50 BioCancell 50 Spiegelmer ® 50 ThyroTec LLC 50 Astex Therapeutics 50 EVIZON TM 50 interferon gamma 1b 50 FDA APPROVES 50 Luveris 50 Completes Previously Announced 50 Orapred ODT 50 FACTIVE R gemifloxacin 50 Extend Collaboration 50 OTCBB PYTO 50 Nasdaq DVAX 50 ddRNAi 50 selective immunoproteasome inhibitor 50 successfully commercialize Silenor 50 TRACON Pharmaceuticals 50 ImmunoCellular Therapeutics 50 Investigational Device Exemption 50 fipamezole 50 PDE# inhibitors 50 Uplyso 50 Abbot Reif Hameiri 50 Aptamer 50 Oasmia 50 RELISTOR ® 50 ZADAXIN ® 50 Grunenthal GmbH 50 lixivaptan 50 Elafin 50 co licensor KDL 50 Trovax 50 Marqibo TM 50 HepaGam B TM 50 Veregen TM 50 memantine HCl 50 Zor Pharmaceuticals 50 miconazole Lauriad ® 50 siRNAs targeting 50 topical non steroidal 50 Campto 50 PRN FDA Approves 50 MAb therapy 50 UCB Pharma SA 50 NKT Therapeutics 50 Elron Electronics 50 Welfare MHLW 50 histone deacetylase inhibitor 50 Vifor Pharma 50 generation purine nucleoside 50 Wellstat 50 DAVANAT ® 50 Kineret 50 BEMA Granisetron 50 Eniluracil 50 Endotis 50 Premarket Approval Application 50 Progenitor Cell 50 Fast Track designations 50 SynCon 50 XL# XL# 50 vaccine GRNVAC1 50 Terminates Merger Agreement 50 Cetrorelix 50 Generic Version 50 Nasdaq CRXL 50 ACAPODENE R 50 ADP receptor antagonist 50 Multaq dronedarone 50 MacroMed 50 Velaglucerase Alfa 50 Sensipar ® 50 SansRosa 50 small molecule thrombopoietin 50 anti CD3 monoclonal 50 5 HT2C 50 Saforis 50 Locked Nucleic Acid 50 Barr ANDA 50 BiovaxID TM 50 pafuramidine maleate 50 chimeric monoclonal antibody 50 orally disintegrating 50 PrevOnco 50 Somatuline Depot 50 Licentia 50 Aloxi Injection 50 Signs Merger Agreement 50 Initiates Clinical Trials 50 intranasal formulation 50 Raptiva R 50 ZBx 50 Nanobody R 50 Lenocta TM 50 Agenerase 50 Biovitrum AB 50 targeted radiotherapeutic 50 Ltd. Nasdaq TEVA 50 Portola Pharmaceuticals 50 Prodrug 50 Vitaros ® 50 Raven Biotechnologies 50 OvaRex ® MAb 50 adenosine A2A 50 Solesta TM 50 Closes Oversubscribed 50 Orally administered 50 Syntonix Pharmaceuticals 50 Kaketsuken 50 Yaakov Edri 50 Chipscreen 50 Captisol ® 50 AERx iDMS 50 phase III isavuconazole 50 CIP Fenofibrate 50 Preotact ® 50 Complete Liquidation 50 MAGE A3 ASCI 50 Investigational Treatment 50 inhalation powder 50 E1 INT TM 50 subsidiary Glenmark Generics 50 Junovan 50 Ipsen SA 50 Enzymotec 50 Launches Generic Version 50 Gastrotech 50 Prism Pharmaceuticals 49 Completes Recapitalization 49 SPRYCEL ® 49 DIFICID ™ 49 Rheoscience 49 drugmaker Teva Pharmaceutical 49 Bellus Health 49 Flamel Technologies Announces 49 Aganocide TM 49 oropharyngeal candidiasis OPC 49 Albugon 49 Opterone R 49 Premarket Approval 49 ELADUR TM 49 PSDV 49 Ness Ziona 49 PER.C6 r 49 SABER ™ 49 Voraxaze 49 refractory acute promyelocytic 49 TheraCIM 49 mesylate 49 Rhucin ® recombinant 49 Gleevec Glivec 49 entity NCE 49 Secretary Telephone +#-#-# 49 BioGeneriX 49 Immune Globulin Human 49 dihydrochloride Tablets 49 Rhein Biotech GmbH 49 Panzem ® 49 Approves Stock Repurchase 49 By JAMAAL ABDUL 49 ProBioGen 49 cinacalcet HCl 49 LIALDA TM 49 Ganciclovir 49 InterfeRx TM 49 Tigecycline 49 JV SpeBio 49 sitagliptin metformin 49 anti infective treatments 49 SomatoKine 49 Solasia 49 Dermylex 49 Pevion Biotech 49 antibacterial therapeutics 49 OTC ZEGERID 49 Anturol TM 49 Gonal f R 49 Executes Agreement 49 faropenem 49 Signs Licensing Agreement 49 AMEX PLX 49 EHT AGN 49 Proneuron Biotechnologies 49 transgenically produced product 49 anti inflammatory NSAID 49 Irinotecan Hydrochloride Injection 49 JOULFERON 49 Inc. OTCBB CYGX 49 Amlodipine Besylate 49 Receives Conditional 49 Generex Oral lyn 49 GMP Certificate 49 Cabilly patent 49 BioMedica 49 oral methylnaltrexone 49 LEVADEX ™ 49 ATryn ® GTC recombinant 49 IMiDs ® 49 Rhucin R 49 Gruppo Angelini 49 oral ghrelin agonist 49 Biologics License Application 49 Zygogen 49 collagenase clostridium histolyticum 49 Amira Pharmaceuticals 49 topical anti infective 49 Teva Pharma 49 Novel Small Molecule 49 Teikoku Seiyaku Co. 49 Transgene Biotek 49 Relieva 49 NASDAQ AVNR 49 ONCASPAR 49 Spokesperson Nabil Abu 49 Nasdaq HALO 49 Proteologics 49 OLEPTRO 49 Nasdaq PARS 49 Diabetic Neuropathy 49 Alexza Pharmaceuticals Inc 49 POSIDUR TM ELADUR TM 49 AMITIZA lubiprostone 49 Kit CD# positive 49 Aflibercept 49 Pruvel 49 Ostarine TM 49 oral salmon calcitonin 49 Kineret R 49 Meda STO MEDAA 49 Biopartners 49 IAP inhibitors 49 RTP #i 49 Prolor Biotech 49 GenWay Biotech 49 cytokine immunomodulator 49 theranostic 49 Kuhnil 49 Single Dose 49 Teva Pharmaceuticals NASDAQ TEVA 49 Acquires Exclusive 49 NASDAQ TEVA 49 R sorafenib tablets 49 Familial Adenomatous Polyposis FAP 49 DURIN TM 49 diarrhea predominant irritable 49 Esteve SA 49 Milestone Payment From 49 Plenaxis R 49 NASDAQ IDEV 49 Product Designation 49 COLAZAL R 49 Announces FDA Clearance 49 Loxapine 49 Kissei Pharmaceuticals 49 SANVAR 49 lexidronam injection 49 Provides Update Regarding 49 Nereus Pharmaceuticals 49 Fortical ® 49 Nostrum Pharmaceuticals 49 RECOTHROM R 49 IV Busulfex 49 Faropenem 49 CIMYM 49 Reports Receipt 49 NYSE BSI hereinafter 49 treat chronic sinusitis 49 IV acetaminophen 49 OMRIX Biopharmaceuticals 49 PSN# [001] 49 Elan Pharma 49 Grünenthal GmbH 49 Fluconazole 49 ISTODAX 49 Vantas 49 CINOD 49 Zenpep 49 Zenvia ™ 49 Anti Infective 49 developing ACAPODENE 49 antibody MT# 49 Sanvar 49 Patent Broadly Covering 49 AtuRNAi 49 NASDAQ CRXL 49 dimesylate 49 sublicensee 49 blood clot dissolver 49 Navelbine R 49 CollaRx GENTAMICIN SURGICAL IMPLANT 49 Dor Alon Energy 49 nonexclusive license 49 Obtains Exclusive License 49 TheraCIM h R3 49 Vidaza R 49 ViaCyte 49 XIAFLEX ™ 49 Ester Neurosciences 49 CIMAB SA 49 Zenyaku Kogyo 49 AMEX HEB 49 vinorelbine tartrate 49 Simulect 49 Tiuxetan 49 Molecular Templates 49 selective modulator 49 Lamotrigine Tablets 49 NASDAQ BDSI 49 CIMZIA ® 49 Digna Biotech 49 non splenectomized 49 Tesamorelin 49 induced macular edema 49 Ltd. TASE 49 Indaflex 49 opioid bowel dysfunction 49 RenaZorb TM 49 Closes Previously Announced 49 Marketing Authorization Applications 49 David Tsur 49 Affitech AS 49 Restanza TM 49 DepoBupivacaine TM 49 NanoPass 49 Ergomed 49 Phase IIb Trial 49 acadesine 49 PharmaSwiss SA 49 Confirms Commitment 49 Procognia 49 NASDQ ROSG 49 Patients Treated With 49 TASE BOSC 49 Receives FDA Clearance 49 registrational studies 49 VALSTAR 49 Multiferon R 49 HA'ARETZ reported 49 Thelin tm 49 thetreatment 49 Nasdaq IDIX 49 Inc. Nasdaq SGXP 49 Seikagaku 48 TAROF 48 Arzerra TM 48 SWX SPPN 48 Troxatyl TM 48 Les Laboratoires Servier 48 Seikagaku Corporation 48 Photodisinfection System 48 HEPLISAV ™ 48 GenSci 48 Receives Regulatory 48 Fabry Disease 48 POSIDUR TM 48 Ltd. TEVA 48 injectable antibiotic 48 Fixed Dose Combination 48 EGRIFTA TM 48 R Saizen R 48 Kosan motilin agonist 48 cetuximab Erbitux R 48 Evoltra ® 48 Ze'ev Elkin 48 insulin glulisine 48 Nycomed GmbH 48 soluble tumor necrosis 48 Zenith Goldline Pharmaceuticals 48 Globes Tel Aviv 48 ORL.TA 48 Swissmedic 48 NASDAQ DRRX 48 overactive bladder VANTAS R 48 subcutaneous formulation 48 BLA filing 48 XIAPEX ® 48 Combidex 48 Inc. Nasdaq MYL 48 telaprevir VX 48 Regains Compliance 48 Nasdaq SPNC 48 Thiovir 48 Receives Patent 48 MUSE ® 48 BioGeneriX AG 48 Inc. NASDAQ CVTX 48 Pre IND 48 Elvitegravir 48 Stanate R 48 Keppra ® levetiracetam 48 Bazedoxifene 48 prasterone 48 Gliadel R 48 R sipuleucel T 48 Aegerion Pharmaceuticals 48 Zentaris 48 Pennsaid R 48 EBx ® 48 Euroscreen 48 ORADUR ® 48 KAI Pharmaceuticals 48 hypoxia activated prodrug 48 Stavzor 48 RAMALLAH MENL 48 Plicera 48 Binui Real Estate 48 NASDAQ SHPGY 48 topical ophthalmic 48 Sinuwave 48 PSD Xetra PSI 48 LibiGel NDA